The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …

On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …

In late 2020, after circulating for almost a year in the human population, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) exhibited a major step change in its adaptation …

SARS-CoV-2 entry requires sequential cleavage of the spike glycoprotein at the S1/S2 and
the S2ʹ cleavage sites to mediate membrane fusion. SARS-CoV-2 has a polybasic insertion (…

Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has caused hundreds of millions of cases and continues to circulate globally. To establish …

Since the first reports of a novel severe acute respiratory syndrome (SARS)-like coronavirus
in December 2019 in Wuhan, China, there has been intense interest in understanding how …

COVID-19 is a disease with unique characteristics that include lung thrombosis 1 , frequent
diarrhoea 2 , abnormal activation of the inflammatory response 3 and rapid deterioration of …

Animal cells harbour multiple innate effector mechanisms that inhibit virus replication. For the
pathogenic retrovirus human immunodeficiency virus type 1 (HIV-1), these include widely …

Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

The spread of the SARS-CoV-2 into a global pandemic within a few months of onset motivates
the development of a rapidly scalable vaccine. Here, we present a self-amplifying RNA …